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NEUROENDOCRINE DIFFERENTIATION IN ADENOCARCINOMA 
OF PROSTATE DURING COMBINED ANDROGEN BLOCKADE 
THERAPY: A CASE REPORT 
Koichiro KITAMOTO， Teruaki HAYASHI， Satoshi TAMADA， Kazuyosi EZA悶，
Hidenori KAWASHIMA， Kazunobu SUGIMURA and Tatsuya NAKATANI 
The Department 01 Urology， Osakaαty University Graduate School 01 Medicine 
Prostatic neuroendocrine (NE) carcinoma is a rare disease with a poor prognosis because of its 
rapid progression and the androgen-independent characteristic， for which no successful therapy is 
available presently.れTereport a case of NE differentiated prostate cancer， which was diagnosed as 
adenocarcinoma initially and progressed with NE differentiation during the combined androgen 
blockade therapy. 
(Hinyokika Kiyo 51: 33-35， 2005) 
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際， PSA 7.2 ng/mlと上昇を認め前立腺生検を施行
した.結果は poorlydifferentiated adenocarcinoma 
であった.画像診断の結果 T3bNOMO(Fig. lA)の








入院時検査所見 RBC 277X 104/μ1， Hb 9.6 g/dl， 
Ht 28.8%， S-Cr 1.26 mg/dlと，貧血と軽度の腎機
能障害が認められた.
腫蕩マーカーである PSAは感度以下であり， CEA 
3.9 ng/ml (正常値0-6.5)，CAI9-945U/ml (正常
値0-37)であった.また NSE16.5 ng/ml (正常値

















存在しており (Fig.2B)， PSA染色陰性で， NSE， 
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Fig. 1. A; At the initial diagnosis， T2 
weighed 恥1RI showed a low-signal 
area suggesting that tumor existed in 
the right lobe of prostate and right 
seminal vesicle. B; At the time of re-
biopsy of prostate， MRI showed that 
prostate was markedly enlarged. 
ニンA，グリメリウス染色は陽性であった.



















Fig. 2. A; Microscopic findings of a biopsy 
specimen at the time of initial diagno-
sis showed poorly differentiated adeno-
carcinoma. B; Microscopic findings 
of a biopsy specimen showed small cel 



















nin A， synaptophysinト7) neural cel adhesion 
molecules (NCAM) 8) などの血液，組織中の検出な
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